Inhibition assay confirming the specificity of the ELISA assay in detecting CD20.

Detection of CD20 in 2 plasma samples from patients with CLL was diminished when increasing amounts of purified CD20 were added to the detecting antibody (horseradish peroxidase-labeled rituximab).